Literature DB >> 22915230

Age at menarche and parity are independently associated with Anti-Müllerian hormone, a marker of ovarian reserve, in Filipino young adult women.

Jared M Bragg1, Christopher W Kuzawa, Sonny S Agustin, Monisha N Banerjee, Thomas W McDade.   

Abstract

OBJECTIVES: Despite ample evidence of variation in timing of menopause, little is known about the extent or underlying causes of individual variation in ovarian reserve and age-related follicular decline. Anti-Müllerian hormone (AMH), a hormonal marker of ovarian reserve, may be a useful tool to clarify these questions. We describe AMH in a cohort of Filipino young adult women, and evaluate whether ovarian reserve in early adulthood relates to measures of life history scheduling (menarcheal age) and reproductive effort (parity).
METHODS: Data and samples are obtained from 294 nonpregnant participants (21.5 years ± 0.3) in the Cebu Longitudinal Health and Nutrition Survey. Plasma AMH was assayed using an enzyme immunoassay and relationships between AMH, menarcheal age, and parity were examined.
RESULTS: Mean AMH was 4.3 ng/mL. In multiple regression models, women who experienced menarche earlier had significantly higher AMH as young adults (P < 0.05). Women with two (P < 0.05) and three or more (P < 0.01) children had significantly lower AMH than those with no children. These associations were independent of age, smoking, and body mass index.
CONCLUSIONS: These findings suggest that individual variation in life history scheduling and reproductive history could contribute to variation in ovarian reserve. Moreover, they demonstrate the utility of AMH as a tool for human reproductive ecology, and highlight the need for further research clarifying the extent of human population variation in ovarian reserve and the behavioral and ecological influences underlying this variation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22915230     DOI: 10.1002/ajhb.22309

Source DB:  PubMed          Journal:  Am J Hum Biol        ISSN: 1042-0533            Impact factor:   1.937


  7 in total

1.  Antimüllerian hormone in relation to tobacco and marijuana use and sources of indoor heating/cooking.

Authors:  Alexandra J White; Dale P Sandler; Aimee A D'Aloisio; Frank Stanczyk; Kristina W Whitworth; Donna D Baird; Hazel B Nichols
Journal:  Fertil Steril       Date:  2016-05-27       Impact factor: 7.329

2.  Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.

Authors:  Seungyoun Jung; Naomi Allen; Alan A Arslan; Laura Baglietto; Louise A Brinton; Brian L Egleston; Roni Falk; Renée T Fortner; Kathy J Helzlsouer; Annika Idahl; Rudolph Kaaks; Eva Lundin; Melissa Merritt; Charlotte Onland-Moret; Sabina Rinaldi; María-José Sánchez; Sabina Sieri; Helena Schock; Xiao-Ou Shu; Patrick M Sluss; Paul N Staats; Ruth C Travis; Anne Tjønneland; Antonia Trichopoulou; Shelley Tworoger; Kala Visvanathan; Vittorio Krogh; Elisabete Weiderpass; Anne Zeleniuch-Jacquotte; Wei Zheng; Joanne F Dorgan
Journal:  Fertil Steril       Date:  2017-04       Impact factor: 7.329

3.  Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women.

Authors:  Kristen Upson; Helen B Chin; Erica E Marsh; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2019-01-14       Impact factor: 2.681

4.  Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa.

Authors:  Kristina W Whitworth; Donna D Baird; Anne Z Steiner; Riana M S Bornman; Gregory S Travlos; Ralph E Wilson; Matthew P Longnecker
Journal:  Epidemiology       Date:  2015-05       Impact factor: 4.822

5.  Is Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR Trial.

Authors:  Shvetha M Zarek; Emily M Mitchell; Lindsey A Sjaarda; Sunni L Mumford; Robert M Silver; Joseph B Stanford; Noya Galai; Mark V White; Karen C Schliep; Alan H DeCherney; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2015-09-25       Impact factor: 5.958

6.  Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.

Authors:  Tess V Clendenen; Wenzhen Ge; Karen L Koenig; Yelena Afanasyeva; Claudia Agnoli; Elizabeth Bertone-Johnson; Louise A Brinton; Farbod Darvishian; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

7.  Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms.

Authors:  Nada Ahmed; Asma A Batarfi; Osama S Bajouh; Sherin Bakhashab
Journal:  Diagnostics (Basel)       Date:  2019-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.